SEC Form 4 · accession 0001209191-17-019383
Veradigm Inc. · MDRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Farley
Officer — SVP Gerneral Counsel & Corpora
Period of report
Mar 6, 2017
Accepted (ET)
Mar 8, 2017 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124804
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2017 | A | 67,058 | $0.00 | A | 155,523 | D | |
| Common Stock | Mar 6, 2017 | F | 5,438 | $11.93 | D | 217,143 | D | |
| Common Stock | Mar 6, 2017 | F | 4,259 | $11.93 | D | 212,884 | D | |
| Common Stock | Mar 6, 2017 | F | 2,054 | $11.93 | D | 210,830 | D | |
| Common Stock | Mar 6, 2017 | A | 11,706 | $0.00 | A | 222,536 | D | |
| Common Stock | Mar 6, 2017 | F | 3,823 | $11.93 | D | 218,713 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Award of service-based Restricted Stock Units granted under the Allscripts Healthcare Solutions, Inc. 2011 Stock Incentive Plan on March 6, 2017 (the "Grant Date"). The award vests 33% per year on each of the first three anniversaries of the Grant Date, subject to achievement of a performance goal for the period ending December 31, 2017
- F2Withholding shares solely to cover withholding tax liabilities in connection with the vesting of performance stock units on March 6, 2017.
- F3On February 25, 2014 (the "Grant Date"), the reporting person was granted performance-based restricted stock units ("PSUs"), the vesting of which was subject to both continued service and a performance measure of a combination of 50% non-GAAP adjusted EBITDA and 50% non-GAAP revenue targets being attained for successive one-year, two-year and three-year performance periods commencing on the Grant Date. The acquisition of shares of the Issuer's common stock represents the vesting of PSUs for the three-year performance period ending three years from the Grant Date.